{
  "section_id": "icu",
  "subsection_id": "icu_infections",
  "title": "عفونت‌های ICU",
  "questions": [
    {
      "id": 1,
      "options": [
        "Start empiric antibiotics فوری (piperacillin-tazobactam + fluoroquinolone)",
        "Endotracheal aspirate (ETA) برای Gram stain + culture + PCR",
        "Bronchoalveolar lavage (BAL) برای quantitative culture",
        "Start empiric antifungal + antibiotics"
      ],
      "analysis": {
        "options": [
          "Empiric antibiotics: reasonable لکن بدون culture بیش‌رو",
          "ETA: diagnostic step اول برای VAP suspicion",
          "BAL: invasive، بعد از failed clinical response",
          "Antifungal: اگر risk factors یا failed therapy"
        ],
        "points": [
          "VAP suspicion: culture و Gram stain diagnostic basis",
          "ETA semi-quantitative: ۱۰³-۱۰۴ CFU clinical threshold",
          "Empiric therapy: بعد از sample collection"
        ]
      },
      "difficulty": "medium",
      "tags": [
        "VAP",
        "ventilator-associated pneumonia",
        "diagnosis",
        "culture"
      ],
      "reference": "VAP Clinical Diagnosis and Microbiological Sampling",
      "question": "بیمار ۶۵ ساله ventilated روز ۵ برای ARDS. درجه حرارت ۳۸.۷°C، سفید خون ۱۳.۲، lactate ۲.۱. تصویر قفسه سینه: bilateral lower lobe infiltrates، purulent sputum. کدام گام اول است؟",
      "correct_index": 1
    },
    {
      "id": 2,
      "options": [
        "Ceftriaxone + vancomycin (single agent therapy)",
        "Piperacillin-tazobactam + ciprofloxacin + vancomycin",
        "Meropenem + tobramycin",
        "Imipenem + levofloxacin"
      ],
      "analysis": {
        "options": [
          "Ceftriaxone + vancomycin: inadequate coverage برای GNB",
          "Piperacillin-tazobactam (GNB coverage) + cipro (coverage اضافی) + vanco (streptococci)",
          "Meropenem + aminoglycoside: غیر بهینه برای مبتدیان",
          "Imipenem + levofloxacin: overlap coverage"
        ],
        "points": [
          "VAP empiric coverage: pseudomonas + MRSA + streptococci",
          "GNB + streptococcal coverage: combination therapy",
          "De-escalation بعد از culture results"
        ]
      },
      "difficulty": "hard",
      "tags": [
        "VAP",
        "antibiotic empiric therapy",
        "gram stain",
        "coverage"
      ],
      "reference": "VAP Empiric Antibiotic Selection Guidelines",
      "question": "بیمار ۵۸ ساله در ICU روز ۸. ETA: Gram negative bacilli (GNB) و gram positive cocci (chains). کدام رژیم آنتی‌بیوتیکی مناسب است؟",
      "correct_index": 1
    },
    {
      "id": 3,
      "options": [
        "Ciprofloxacin IV high-dose (800 mg Q8H)",
        "Amikacin IV (۲۰ mg/kg) + fluoroquinolone",
        "Colistin (polymyxin E)",
        "Fluoroquinolone تنهایی (monotherapy)"
      ],
      "analysis": {
        "options": [
          "Ciprofloxacin تنها: resistance development risk",
          "Amikacin + fluoroquinolone: synergy و resistance prevention",
          "Colistin: آخری resort برای multi-drug resistant",
          "Monotherapy fluoroquinolone: inadequate combination"
        ],
        "points": [
          "Pseudomonas: combination therapy بهتر از monotherapy",
          "Aminoglycoside + fluoroquinolone: standard approach",
          "Duration VAP: ۷-۱۰ روز معمول"
        ]
      },
      "difficulty": "hard",
      "tags": [
        "Pseudomonas",
        "VAP",
        "antibiotic combination",
        "resistance"
      ],
      "reference": "Pseudomonas aeruginosa VAP Management",
      "question": "بیمار ۶۲ ساله با ventilator-associated pneumonia. ETA: Pseudomonas aeruginosa (susceptible تنها برای fluoroquinolone و amikacin). کدام انتخاب مناسب است؟",
      "correct_index": 1
    },
    {
      "id": 4,
      "options": [
        "CRBSI (Central Line-Related Bloodstream Infection)",
        "Septic thrombophlebitis",
        "Contamination نمونه خون",
        "SIRS از دیگر source"
      ],
      "analysis": {
        "options": [
          "CRBSI: fever + chills پس از CVC within ۴۸ ساعت",
          "Septic thrombophlebitis: بعدی اگر untreated CRBSI",
          "Contamination: single culture positive است",
          "SIRS: less specific برای line-related"
        ],
        "points": [
          "CRBSI diagnosis: blood culture (peripheral + through line)",
          "Timing: fever within ۴۸ ساعت CVC insertion",
          "Immediate culture + remove line اگر suspicion"
        ]
      },
      "difficulty": "medium",
      "tags": [
        "CRBSI",
        "catheter-related",
        "bloodstream infection",
        "fever"
      ],
      "reference": "CRBSI Diagnosis and Management Guidelines",
      "question": "بیمار ۴۸ ساله در ICU روز ۳ با fever و chills پس از CVC insertion. Hemolytic، HR ۱۱۵، BP ۹۲/۶۰. کدام تشخیص احتمالی است؟",
      "correct_index": 0
    },
    {
      "id": 5,
      "options": [
        "Remove CVC + vancomycin IV × ۱۰-۱۴ روز",
        "Antibiotic lock therapy فقط (بدون removal)",
        "Remove CVC + vancomycin ۱۴-۲۸ روز + echocardiography",
        "Culture-directed therapy بدون CVC removal اگر clinically stable"
      ],
      "analysis": {
        "options": [
          "Remove + ۱۰-۱۴ روز: برای غیر-complicated CRBSI",
          "Antibiotic lock: only برای salvage attempt",
          "Remove + طولانی‌تر duration + echo: complicated CRBSI",
          "Line retention: high risk endocarditis"
        ],
        "points": [
          "MRSA CRBSI: MUST remove line",
          "Duration: ۱۴-۲۸ روز برای MRSA",
          "Echocardiography: exclude endocarditis"
        ]
      },
      "difficulty": "hard",
      "tags": [
        "CRBSI",
        "MRSA",
        "line removal",
        "endocarditis"
      ],
      "reference": "CRBSI Management and CVC Removal Decisions",
      "question": "بیمار ۵۵ ساله با CRBSI. Paired blood cultures: MRSA از هر دو (peripheral و via line). کدام اقدام درست است؟",
      "correct_index": 2
    },
    {
      "id": 6,
      "options": [
        "Start fluconazole IV (monotherapy)",
        "Assess risk: if risk factors → treat؛ if not → monitor",
        "Start echinocandin + voriconazole (combination)",
        "Antifungal نه توصیه شده (Candida oral flora است)"
      ],
      "analysis": {
        "options": [
          "Fluconazole: reasonable لکن risk assessment ضروری",
          "Risk stratification: duration ventilation، immunosuppression، etc",
          "Combination: over-treatment برای respiratory colonization",
          "No treatment: risky اگر risk factors دارد"
        ],
        "points": [
          "Candida in sputum: colonization vs infection تمیز کن",
          "Risk factors: ICU >۷ روز، antibiotics، immunosuppression",
          "Treatment: اگر risk factors یا worsening clinical"
        ]
      },
      "difficulty": "hard",
      "tags": [
        "Candida",
        "respiratory",
        "colonization",
        "antifungal"
      ],
      "reference": "Candida Respiratory Infection vs Colonization Guidelines",
      "question": "بیمار ۶۸ ساله در ICU روز ۱۲ با fever، sputum مورد بررسی: Candida albicans. کدام تصمیم درست است؟",
      "correct_index": 1
    },
    {
      "id": 7,
      "options": [
        "Fluconazole IV (۴۰۰ mg loading پھر ۲۰۰-۴۰۰ mg)",
        "Echinocandin (micafungin/anidulafungin) اول",
        "Amphotericin B liposomal",
        "Voriconazole"
      ],
      "analysis": {
        "options": [
          "Fluconazole: مناسب برای C. parapsilosis (non-albicans susceptible)",
          "Echinocandin: برای C. auris یا albicans severe",
          "Amphotericin: reserved برای resistant species",
          "Voriconazole: not first-line برای candidemia"
        ],
        "points": [
          "C. parapsilosis: fluconazole-susceptible species",
          "Duration: ۲ هفته بعد از last positive culture",
          "Remove CVC اگر possible"
        ]
      },
      "difficulty": "medium",
      "tags": [
        "candidemia",
        "Candida parapsilosis",
        "fluconazole",
        "bloodstream infection"
      ],
      "reference": "Candidemia Management Guidelines IDSA",
      "question": "بیمار ۶۲ ساله با candidemia. Candida parapsilosis از blood culture. کدام انتخاب مناسب است؟",
      "correct_index": 0
    },
    {
      "id": 8,
      "options": [
        "Continue same therapy (ESBL E. coli تا اکنون تحت کنترل)",
        "Carbapenem (meropenem یا imipenem) + aminoglycoside",
        "Colistin monotherapy",
        "Add vancomycin (supplemental coverage)"
      ],
      "analysis": {
        "options": [
          "Continue: ESBL مقاوم به beta-lactam/inhibitor است",
          "Carbapenem: gold standard برای ESBL",
          "Colistin: آخری resort، نه اول escalation",
          "Vancomycin: not relevant برای gram-negative"
        ],
        "points": [
          "ESBL: مقاوم به third-generation cephalosporin",
          "Carbapenem: نفوذپذیر مقاومت ESBL",
          "Duration: ۷-۱۰ روز VAP معمول"
        ]
      },
      "difficulty": "hard",
      "tags": [
        "ESBL",
        "VAP",
        "escalation",
        "carbapenem"
      ],
      "reference": "ESBL Gram-Negative Infection Management",
      "question": "بیمار ۵۲ ساله با presumed VAP. Day ۲ therapy: سوخت‌طلب antibiotics (کنترل‌نشده). دوباره culture: ESBL-producing E. coli. کدام escalation مناسب است؟",
      "correct_index": 1
    },
    {
      "id": 9,
      "options": [
        "Ceftriaxone IV (۱ g Q۸H)",
        "Piperacillin-tazobactam + ciprofloxacin",
        "Vancomycin + carbapenem",
        "Levofloxacin monotherapy"
      ],
      "analysis": {
        "options": [
          "Ceftriaxone: adequate برای penicillin-susceptible pneumococcus",
          "Piperacillin-tazobactam: overkill برای non-Pseudomonas HAP",
          "Vancomycin + carbapenem: excessive، MRSA نیست",
          "Fluoroquinolone monotherapy: less optimal"
        ],
        "points": [
          "HAP vs VAP: risk stratification متفاوت",
          "No Pseudomonas: simplified coverage",
          "De-escalation: به ceftriaxone monotherapy"
        ]
      },
      "difficulty": "medium",
      "tags": [
        "HAP",
        "hospital-acquired pneumonia",
        "penicillin-susceptible",
        "streptococcus"
      ],
      "reference": "HAP vs VAP Management Distinction",
      "question": "بیمار ۶۵ ساله با HAP (بیمارستانی اما غیر ICU). Sputum: Streptococcus pneumoniae (penicillin-susceptible)، no Pseudomonas risk. کدام رژیم مناسب است؟",
      "correct_index": 0
    },
    {
      "id": 10,
      "options": [
        "Continue same antibiotics تا ۷ روز کامل",
        "De-escalate به narrow-spectrum antibiotics",
        "Stop antibiotics (clinical improvement)",
        "Extend تا ۱۴ روز (prophylaxis)"
      ],
      "analysis": {
        "options": [
          "Continue: standard duration ۷-۸ روز VAP",
          "De-escalate: بعد از culture results specified",
          "Stop early: risk recurrence",
          "Extend ۱۴ روز: evidence not support"
        ],
        "points": [
          "VAP duration: ۷-۱۰ روز optimum",
          "Shorter therapy: similar outcomes + less resistance",
          "Clinical improvement: نشان‌دهنده effective therapy"
        ]
      },
      "difficulty": "medium",
      "tags": [
        "VAP",
        "duration therapy",
        "clinical improvement",
        "de-escalation"
      ],
      "reference": "Duration of Antibiotic Therapy in VAP",
      "question": "بیمار ۵۹ ساله ventilated روز ۷ با VAP. Day ۳ therapy: کاهش fever، WBC normalizing، sputum کاهش. کدام اقدام مناسب است؟",
      "correct_index": 0
    },
    {
      "id": 11,
      "options": [
        "Surgical site infection (superficial incisional)",
        "Intra-abdominal infection/anastomotic leak",
        "Bloodstream infection فقط",
        "SIRS post-operative معمول"
      ],
      "analysis": {
        "options": [
          "Superficial: عام‌تر لکن turbid drainage نشان‌دهنده deeper",
          "Intra-abdominal: drain evidence، urgent intervention",
          "BSI: may accompany لکن drain finding اول",
          "SIRS: نیاز clinical assessment"
        ],
        "points": [
          "Turbid drain fluid: bacterial contamination احتمالی",
          "Urgent: culture drain + imaging + surgery consult",
          "Post-op day ۴: early infection window"
        ]
      },
      "difficulty": "medium",
      "tags": [
        "post-operative infection",
        "intra-abdominal",
        "drainage",
        "fever"
      ],
      "reference": "Post-operative Intra-abdominal Infection Diagnosis",
      "question": "بیمار ۶۰ ساله در ICU روز ۴ بعد از abdominal surgery. Fever ۳۸.۹°C، peritoneal drain: turbid fluid. کدام تشخیص احتمالی است؟",
      "correct_index": 1
    },
    {
      "id": 12,
      "options": [
        "Colistin (polymyxin E) میلی‌گرم/کیلو‌گرم/روز",
        "Tigecycline monotherapy",
        "Colistin + rifampicin (synergy)",
        "Aerosolized colistin (برای VAP)"
      ],
      "analysis": {
        "options": [
          "Colistin: monotherapy inadequate برای serious infection",
          "Tigecycline: possibly susceptible، لکن colistin اول",
          "Colistin + rifampicin: synergy data + combination",
          "Aerosolized: برای respiratory tract، نه BSI"
        ],
        "points": [
          "MDR-AB: limited options available",
          "Combination therapy: بهتر outcomes برای serious",
          "Colistin nephrotoxicity: monitor closely"
        ]
      },
      "difficulty": "hard",
      "tags": [
        "MDR",
        "Acinetobacter baumannii",
        "colistin",
        "bloodstream infection"
      ],
      "reference": "MDR-AB Management and Colistin Use",
      "question": "بیمار ۵۶ ساله با sepsis و multi-drug-resistant Acinetobacter baumannii (MDR-AB) از blood. Only susceptible تا colistin. کدام شود؟",
      "correct_index": 2
    },
    {
      "id": 13,
      "options": [
        "Continue echinocandin، cultures may persist",
        "Switch تا voriconazole (alternative coverage)",
        "Add lipid formulation amphotericin B",
        "Line removal + source control assessment"
      ],
      "analysis": {
        "options": [
          "Continue: Candida auris خطرناک است، persistence sign",
          "Switch: may try لکن source control مهم‌تر",
          "Add amphotericin: combination therapy optional",
          "Remove line + assess source: essential step"
        ],
        "points": [
          "C. auris: high-mortality pathogen",
          "Persistent bacteremia: source control چک‌کن",
          "Line removal: often necessary تا sterilize blood"
        ]
      },
      "difficulty": "hard",
      "tags": [
        "Candida auris",
        "fungemia",
        "persistent",
        "source control"
      ],
      "reference": "Candida auris Infection Management MMWR",
      "question": "بیمار ۶۳ ساله در ICU با fungemia (Candida auris). Echinocandin treatment شروع‌شده. Day ۵: repeat culture still positive. کدام اقدام درست است؟",
      "correct_index": 3
    },
    {
      "id": 14,
      "options": [
        "Early: <۲ روز intubation؛ Late: ≥۲ روز",
        "Early: <۴۸ ساعت intubation؛ Late: ≥۴۸ ساعت",
        "Early: <۳ روز intubation؛ Late: ≥۳ روز",
        "تقسیم‌بندی بر اساس severity آن نه timing"
      ],
      "analysis": {
        "options": [
          "۲ روز: غیر‌دقیق، بیشتر sources ۴۸ ساعت",
          "۴۸ ساعت: standard cutoff early vs late VAP",
          "۳ روز: نه standard",
          "Severity: not relevant برای این classification"
        ],
        "points": [
          "Early-onset VAP: more likely community pathogens",
          "Late-onset VAP: MDR pathogens احتمالی",
          "Timing: coverage strategy تعیین‌کننده"
        ]
      },
      "difficulty": "easy",
      "tags": [
        "VAP",
        "early-onset",
        "late-onset",
        "classification"
      ],
      "reference": "VAP Early vs Late Onset Classification",
      "question": "بیمار ۵۲ ساله ventilated روز ۶ با مشکوک VAP. Early-onset VAP vs late-onset؟ کدام مقسوم‌بندی صحیح است؟",
      "correct_index": 1
    },
    {
      "id": 15,
      "options": [
        "Ceftriaxone IV یا ampicillin-sulbactam",
        "Piperacillin-tazobactam + vancomycin + ciprofloxacin",
        "Meropenem + tobramycin",
        "Fluoroquinolone تنهایی"
      ],
      "analysis": {
        "options": [
          "Ceftriaxone/ampicillin-sulbactam: adequate برای early H. influenzae",
          "Triple therapy: over-treatment برای early-onset",
          "Carbapenem: excessive برای حساس organism",
          "Monotherapy: inadequate coverage"
        ],
        "points": [
          "Early-onset VAP: community-like organisms",
          "H. influenzae: beta-lactam و aminopenicillin sensitive",
          "De-escalation: narrow spectrum اگر culture confirm"
        ]
      },
      "difficulty": "medium",
      "tags": [
        "early-onset VAP",
        "Haemophilus influenzae",
        "de-escalation"
      ],
      "reference": "Early-onset VAP Antibiotic Selection",
      "question": "بیمار ۶۴ ساله با early-onset VAP (day ۲ ventilation). Sputum Gram stain: Haemophilus influenzae (presumed). کدام rژیم مناسب است؟",
      "correct_index": 0
    }
  ]
}